| Literature DB >> 36059862 |
Waka Nogami1, Atsuo Nakagawa1,2, Noriko Kato1,3, Yohei Sasaki1, Taishiro Kishimoto1,4, Masaru Horikoshi3, Masaru Mimura1.
Abstract
Remote cognitive and behavioral therapy (CBT) via videoconference has been garnering attention as a means of improving access to CBT for depression, in particular during the coronavirus disease 2019 pandemic. However, there is a lack of evidence supporting its implementation in Japanese clinical settings. This case series aimed to establish preliminary evidence of whether remote CBT can be an effective therapy for major depression in Japanese clinical settings. Five patients who met the diagnostic criteria for major depressive disorder were enrolled and underwent remote CBT via videoconference and face-to-face assessment interviews. The results showed that remote CBT via videoconference improved depressive symptoms, enabling a relatively high level of patient satisfaction and working alliance. Moreover, detailed feedback from our patients showed that continuous monitoring was preferable for increasing treatment engagement. Further research is warranted to test the efficacy and acceptability of remote CBT via videoconference for treating major depression.Entities:
Keywords: BDI, Beck Depression Inventory; CBT, Cognitive behavioral therapy; COVID-19, coronavirus disease 2019; CSQ-8, Client Satisfaction Questionnaire; DSM, Diagnostic and Statistical Manual of Mental Disorders; M.I.N.I., Mini International Neuropsychiatric Interview; SCID-I/P for DSM-IV-TR, Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition; SRS, Session Rating Scale; cognitive behavioral therapy; depression; teletherapy; videoconference
Year: 2022 PMID: 36059862 PMCID: PMC9417319 DOI: 10.1016/j.cbpra.2022.04.002
Source DB: PubMed Journal: Cogn Behav Pract ISSN: 1077-7229
Five Patients’ Sociodemographic Characteristics at Baseline
| Age | Gender | Education, y | Work status | Marital status | No. of depressive episodes | Duration of index depressive episode, y | Duration of current depressive episode, mo | Used antidepressant | Experience using videoconference | |
|---|---|---|---|---|---|---|---|---|---|---|
| Patient 1 | 45 | Female | 16 | Housewife | Married | 3 | 4 | 5 | Escitaroplam 10 mg | Some |
| Patient 2 | 24 | Male | 16 | On sick leave | Unmarried | 1 | 1 | 5 | Miltazapine 45 mg | Often |
| Patient 3 | 33 | Male | 15 | Unemployed | Unmarried | 4 | 10 | 2 | No antidepressant | Some |
| Patient 4 | 45 | Female | 14 | On sick leave | Unmarried | 2 | 17 | 9 | Duloxetine 20 mg | Little |
| Patient 5 | 40 | Male | 20 | On sick leave | Married | 3 | 17 | 2 | Escitaroplam 10 mg | Very often |
‘Experience using videoconference’ was assessed on a 5-point Likert scale (none, little, some, often, and very often). y = years; mo = months.
Fig. 1Changes in depressive symptoms based on Beck Depression Inventory-II scores over time.Note. BDI-II scores at baseline, middle, and posttreatment. The mean score changed from 34.80 (SD 9.66) at baseline to 19.60 (SD 10.52) posttreatment. BDI-II = Beck Depression Inventory Second Edition; SD = standard deviation.
Fig. 2Changes in patient satisfaction based on the CSQ-8J.Note. CSQ-8J scores at baseline and posttreatment. The mean score changed from 23.00 (SD 3.58) at baseline to 27.60 (SD 4.84) at posttreatment. CSQ-8J = The Client Satisfaction Questionnaire 8 item Japanese version; SD = standard deviation.
Fig. 3Level of working alliance based on the Session Ratings Scale at each session.Note. Remote CBT was administered to all patients. The mean Session Rating Scale score for all patients at the last session was 38.64 (SD 1.56). SRS = Session Rating Scale; SD = standard deviation; no. = number.